We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+5.61%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$375M
AUM Growth
+$5.98M
Cap. Flow
-$10.7M
Cap. Flow %
-2.85%
Top 10 Hldgs %
17.55%
Holding
221
New
23
Increased
111
Reduced
62
Closed
17

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$6.47M
2
ACAD icon
Acadia Pharmaceuticals
ACAD
+$4.68M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$2.92M
4
CYBR
CyberArk
CYBR
+$2.32M
5
SANM icon
Sanmina
SANM
+$1.37M

Top Sells

Rank Stock Value
1
PANW icon
Palo Alto Networks
PANW
+$10.2M
2
INGR icon
Ingredion
INGR
+$8.28M
3
MDU icon
MDU Resources
MDU
+$8.08M
4
DIS icon
Walt Disney
DIS
+$6.24M
5
SUPN icon
Supernus Pharmaceuticals
SUPN
+$5.34M

Sector Composition

Rank Sector Weight
1 Healthcare 17.78%
2 Technology 15.38%
3 Industrials 12.46%
4 Consumer Staples 9.28%
5 Materials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NAVG
176
DELISTED
Navigators Group Inc
NAVG
$506K 0.14%
+8,669
New +$484K
FNHC
177
DELISTED
FedNat Holding Company Common Stock
FNHC
$486K 0.13%
31,165
+3,841
+14% +$58.1K
VCIT icon
178
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.1B
$485K 0.13%
5,509
-279
-5% -$24.5K
RICK icon
179
RCI Hospitality Holdings
RICK
$199M
$484K 0.13%
+19,563
New +$467K
NUE icon
180
Nucor
NUE
$56.5B
$470K 0.13%
8,387
+986
+13% +$55.7K
SCG
181
DELISTED
Scana
SCG
$421K 0.11%
8,690
+1,787
+26% +$110K
SHV icon
182
iShares 0-1 Year Treasury Bond ETF
SHV
$20.8B
$398K 0.11%
3,609
-172
-5% -$19K
IJR icon
183
iShares Core S&P Small-Cap ETF
IJR
$109B
$368K 0.1%
4,964
-717
-13% -$50.2K
KWR icon
184
Quaker Houghton
KWR
$2.64B
$355K 0.09%
2,400
-800
-25% -$114K
CCL icon
185
Carnival Corporation Ltd
CCL
$36.1B
$348K 0.09%
5,393
+1,270
+31% +$84.9K
MSFT icon
186
Microsoft
MSFT
$2.86T
$329K 0.09%
4,421
-542
-11% -$39.6K
MWA icon
187
Mueller Water Products
MWA
$3.92B
$327K 0.09%
+25,515
New +$303K
CVX icon
188
Chevron
CVX
$388B
$309K 0.08%
2,628
-700
-21% -$76.4K
BSTC
189
DELISTED
BioSpecifics Technologies Corp.
BSTC
$288K 0.08%
6,190
-6,356
-51% -$304K
XOM icon
190
ExxonMobil
XOM
$650B
$276K 0.07%
3,372
-569
-14% -$45.2K
PPL
191
PPL Corp
PPL
$27.4B
$264K 0.07%
6,954
-1,538
-18% -$59.5K
MFC icon
192
Manulife Financial
MFC
$72.3B
$234K 0.06%
11,542
– –
COP icon
193
ConocoPhillips
COP
$147B
$233K 0.06%
4,648
-55
-1% -$2.47K
SGEN
194
DELISTED
Seagen Inc. Common Stock
SGEN
$214K 0.06%
+3,940
New +$202K
CL icon
195
Colgate-Palmolive
CL
$72.4B
$207K 0.06%
+2,839
New +$205K
SXT icon
196
Sensient Technologies
SXT
$5.39B
$205K 0.05%
2,667
-690
-21% -$52.3K
IART icon
197
Integra LifeSciences
IART
$1.54B
$202K 0.05%
4,000
– –
DDC
198
DELISTED
Dominion Diamond Corporation
DDC
$162K 0.04%
11,418
– –
FLG
199
Flagstar Bank National Association
FLG
$5.76B
$137K 0.04%
3,533
– –
DMF
200
DELISTED
BNY Mellon Municipal Income
DMF
$95K 0.03%
10,372
– –
5 6 7
8
9

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Stanley-Laman Group's Q3 2017 Portfolio in Review

As of Q3 2017, Stanley-Laman Group held 221 positions worth $375M, up 1.6% from $369M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Stanley-Laman Group's Q3 2017 filing shows 23 new, 111 increased, 62 reduced and 17 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 73,226 shares worth $6.82M. The largest sale was Palo Alto Networks, an estimated $10.2M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

  • Stanley-Laman Group's largest Q3 2017 buy was BioMarin Pharmaceuticals: 73,226 shares worth $6.82M.
  • Stanley-Laman Group added most to Zix Corporation in Q3 2017, an estimated $1.31M increase.
  • Stanley-Laman Group's biggest Q3 2017 reduction was Palo Alto Networks, cutting an estimated $10.2M.
  • Stanley-Laman Group fully exited Supernus Pharmaceuticals in Q3 2017, selling an estimated $5.34M.
  • Stanley-Laman Group's ten largest holdings make up 18% of its $375M portfolio in Q3 2017.
  • Stanley-Laman Group opened 23 new positions and closed 17 in Q3 2017.
  • Stanley-Laman Group's portfolio value rose 1.6% quarter-over-quarter to $375M.

Based on Stanley-Laman Group's 13F filing for Q3 2017, filed 13 Nov 2017.